CHELSEY CAMERON: Open Payments
NPI 1205292034 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $168 |
| Dexcom, Inc. | 1 | $145 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
Products named: TEPEZZA, DEXCOM G7 GSS (161), AIRSUPRA.
Industry payments across TX — which companies pay providers there.
